Eiger BioPharmaceuticals, Inc.
USD1.73
+0.00 (+0.00%)
CEO
David Apelian
IPO Date
2014-01-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.90
Prev. Close
$1.73
Day Low
$1.73
Day High
$1.90
52W Low
$1.73
52W High
$1.90
Market Cap
$0.00B
Volume
0.14M
| 100,000 |
| $0.28 |
| 2 Nov 2023 | KAYNE RICHARD A | 10 percent owner | P-Purchase | Acquired | 130,509 | $0.24 |
| 2 Nov 2023 | KAYNE RICHARD A | 10 percent owner | P-Purchase | Acquired | 12,345 | $0.26 |
| 2 Nov 2023 | KAYNE RICHARD A | 10 percent owner | P-Purchase | Acquired | 11,987 | $0.26 |
| 30 Oct 2023 | KAYNE RICHARD A | 10 percent owner | Disposed | 0 | $0.00 |
| 30 Oct 2023 | KAYNE RICHARD A | 10 percent owner | Disposed | 0 | $0.00 |
| 30 Oct 2023 | KAYNE RICHARD A | 10 percent owner | Disposed | 0 | $0.00 |
| 6 Jul 2023 | Apelian David | director, officer: CEO | A-Award | Acquired | 750,000 | $0.73 |
| 2 May 2023 | Vollins James | General Counsel | A-Award | Acquired | 120,000 | $1.03 |